Related Experiment Video
Updated: Mar 15, 2026

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
Published on: March 26, 2018
Aortic Stenosis-Associated Cardiac Damage: A Comparison Between Patients Treated with Surgery and Transcatheter
Ricardo Román1, Fabián Islas2, Patrick O'Neill-González1
1Instituto Cardiovascular, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), 28040 Madrid, Spain.
Insights
Patients undergoing transcatheter aortic valve replacement (TAVR) for severe aortic stenosis (AS) show more extensive cardiac damage than surgical aortic valve replacement (SAVR) patients. Earlier intervention before advanced damage may improve outcomes.
Area of Science:
- Cardiology
- Cardiac Surgery
- Interventional Cardiology
Background:
- Severe aortic stenosis (AS) can lead to extra-valvular cardiac damage.
- This damage is linked to patient outcomes after aortic valve interventions.
Purpose of the Study:
- To compare AS-related cardiac damage between surgical aortic valve replacement (SAVR) and transcatheter aortic valve replacement (TAVR) patients.
- To analyze the impact of cardiac damage stages on 1-year mortality post-intervention.
Main Methods:
- Retrospective analysis of 874 patients with severe AS undergoing SAVR or TAVR (2017-2022).
- Comparison of pre-intervention clinical and echocardiographic parameters.
- Classification of patients using Généreux and Gutiérrez-Ortiz staging systems for cardiac damage.
- Assessment of 1-year all-cause mortality based on damage stages.
Main Results:
- TAVR patients were older, more frequently female, and had higher surgical risk than SAVR patients.
- TAVR patients exhibited significantly more advanced cardiac damage (right-sided) compared to SAVR patients, per both staging systems.
- Higher mortality was observed in patients with right-sided damage, irrespective of intervention type or staging system.
Conclusions:
- Contemporary severe symptomatic AS patients treated with TAVR present with more extensive cardiac damage than SAVR patients.
- This highlights the importance of intervention timing, particularly for TAVR candidates.
- Earlier intervention prior to advanced cardiac damage may lead to improved patient outcomes.
Abstract:
Background/Objectives: In patients with severe aortic stenosis (AS), extra valvular cardiac damage is associated with outcomes following intervention. We aimed to analyze differences in AS-related cardiac damage between surgical aortic valve replacement (SAVR) and transcatheter aortic valve replacement (TAVR) patients in a contemporary cohort of patients with severe AS. Methods: Patients who underwent SAVR or TAVR in a tertiary care center from 2017 to 2022 were included in this retrospective analysis. Clinical and echocardiographic parameters before surgery were compared, and patients were classified according to two available cardiac damage staging systems. Additionally, all-cause mortality 1-year post-intervention was assessed according to these stages. Results: Eight hundred and seventy-four patients were included (524 underwent TAVR and 350 underwent SAVR). TAVR patients were significantly older (81.9 ± 6.1 vs. 69.5 ± 9.5 years; p < 0.001), more commonly female (52.4% vs. 37.7%; p < 0.001), and had higher surgical risk (EuroSCORE II 6.2 ± 7.0 vs. 2.7 ±3.3; p < 0.001). Compared with SAVR, patients treated with TAVR had significantly more advanced (right-sided) cardiac damage, both with Généreux (37.8% vs. 23.1%; p < 0.001) and Gutiérrez-Ortiz (16.5% vs. 9.0%; p = 0.007) staging systems. Moreover, regardless of the type of intervention or the staging system used, mortality was significantly higher in patients with right-sided damage. Conclusions: In a contemporary cohort of severe symptomatic AS patients, those treated with TAVR had significantly more extensive cardiac damage compared with those who underwent SAVR. This finding raises the question of when to intervene in patients chosen for TAVR. Earlier intervention, before advanced cardiac damage ensues, might help to improve outcomes.
Related Concept Videos
Mitral Stenosis III: Medical Management
Aortic Regurgitation III: Medical Management
Aortic Regurgitation II: Clinical Features and Diagnostic Tests

